Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lexaria Bioscience Corp. - Common Stock
(NQ:
LEXX
)
0.5879
+0.0179 (+3.14%)
Streaming Delayed Price
Updated: 11:20 AM EDT, Jul 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
24,973
Open
0.5700
Bid (Size)
0.5600 (1,400)
Ask (Size)
0.5850 (500)
Prev. Close
0.5700
Today's Range
0.5600 - 0.6001
52wk Range
0.4600 - 1.550
Shares Outstanding
24,887,446
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
June 25, 2026
From
Lexaria Bioscience Corp.
Via
ACCESS Newswire
Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule
June 23, 2026
From
Lexaria Bioscience Corp.
Via
ACCESS Newswire
Performance
YTD
-10.1%
-10.1%
1 Month
-4.6%
-4.6%
3 Month
-32.1%
-32.1%
6 Month
-4.7%
-4.7%
1 Year
-30.8%
-30.8%
More News
Read More
GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand
June 17, 2026
From
Lexaria Bioscience Corp.
Via
ACCESS Newswire
Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
June 09, 2026
Via
ACCESS Newswire
Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program
June 03, 2026
Via
ACCESS Newswire
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
May 19, 2026
Via
ACCESS Newswire
Lexaria Bioscience Releases Second Episode of Investor Video Series
May 07, 2026
Via
ACCESS Newswire
Lexaria Updates Progress on Human Study #7
May 05, 2026
Via
ACCESS Newswire
Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications
May 01, 2026
Via
ACCESS Newswire
Wednesday's session: top gainers and losers
↗
April 29, 2026
Via
Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session.
↗
April 29, 2026
Via
Chartmill
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
April 29, 2026
Via
ACCESS Newswire
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
April 23, 2026
Via
ACCESS Newswire
Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales
April 21, 2026
Via
ACCESS Newswire
Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property
April 15, 2026
Via
ACCESS Newswire
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
April 07, 2026
Via
ACCESS Newswire
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
April 07, 2026
Via
TheNewswire.com
Lexaria to Begin New Human Clinical Study in GLP-1
April 01, 2026
Via
ACCESS Newswire
Lexaria's Robust Patent Portfolio Continues to Grow
March 26, 2026
Via
ACCESS Newswire
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
March 24, 2026
Via
ACCESS Newswire
Lexaria Announces New R&D Plans for 2026
March 04, 2026
Via
ACCESS Newswire
Lexaria Announces Positive Final Results From Human Pilot Study #5
February 05, 2026
Via
ACCESS Newswire
Lexaria Awarded Six Additional Patents
January 22, 2026
Via
TheNewswire.com
Topics
Intellectual Property
Lexaria Awarded Six Additional Patents
January 22, 2026
Via
ACCESS Newswire
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
January 21, 2026
From
USA News Group
Via
GlobeNewswire
Frequently Asked Questions
Is Lexaria Bioscience Corp. - Common Stock publicly traded?
Yes, Lexaria Bioscience Corp. - Common Stock is publicly traded.
What exchange does Lexaria Bioscience Corp. - Common Stock trade on?
Lexaria Bioscience Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lexaria Bioscience Corp. - Common Stock?
The ticker symbol for Lexaria Bioscience Corp. - Common Stock is LEXX on the Nasdaq Stock Market
What is the current price of Lexaria Bioscience Corp. - Common Stock?
The current price of Lexaria Bioscience Corp. - Common Stock is 0.5879
When was Lexaria Bioscience Corp. - Common Stock last traded?
The last trade of Lexaria Bioscience Corp. - Common Stock was at 07/02/26 11:20 AM ET
What is the market capitalization of Lexaria Bioscience Corp. - Common Stock?
The market capitalization of Lexaria Bioscience Corp. - Common Stock is 14.63M
How many shares of Lexaria Bioscience Corp. - Common Stock are outstanding?
Lexaria Bioscience Corp. - Common Stock has 15M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
